Xavier Yon
Advisory Board Member
Elastagen
Australia
Biography
Xavier Yon is a seasoned healthcare executive with an extensive background in dermatology. Previous roles include executive positions with Pfizer, Solvay, Alcon and most notably as Chief Executive Officer of Galderma for 17 years. During his time at Galderma Xavier built the company from its initial spin out from Alcon to be a world leader in ethical dermatology. Galderma currently has over 3,000 employees and $2 Billion in revenue. More recently Xavier has served as a Member of the Board of Directors at Graceway Pharmaceuticals (USA), which was acquired by Medicis in 2011. In addition to his position with Elastagen, Xavier currently serves as a Member of the Board of Directors at Photocure (Norway), a pioneer of Photo Dynamic Therapy and Virbac (France), a global leader in animal health. Xavier holds a degree in Physics, Chemistry and Biology from Sorbonne University, Paris and attended the Advanced Management Program at Harvard University.
Research Interest
research interest on Business Development
